Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-12-20
2005-12-20
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S256000, C514S300000, C514S307000, C514S311000, C514S316000, C514S326000, C544S333000, C546S122000, C546S139000, C546S152000, C546S202000, C546S205000, C546S212000
Reexamination Certificate
active
06977265
ABSTRACT:
The invention provides compounds of Formula (I):wherein: R1-R5, A, L, and X have any of the values defined in the specification that are CCR-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use, and methods and intermediates useful for preparing them.
REFERENCES:
patent: 5147876 (1992-09-01), Mizuchi et al.
patent: 6331541 (2001-12-01), Ko et al.
patent: WO 00/35449 (2000-06-01), None
patent: WO 00/35451 (2000-06-01), None
patent: WO 00/35452 (2000-06-01), None
patent: WO 00/35453 (2000-06-01), None
patent: WO 00/35454 (2000-06-01), None
patent: WO 01/87838 (2001-11-01), None
Du Bois Daisy Joe
Kertesz Denis John
Sjogren Eric Brian
Smith David Bernard
Wang Beihan
Chang Celia
Green Grant D.
Roche Palo Alto LLC
LandOfFree
Piperidine CCR-3 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperidine CCR-3 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidine CCR-3 receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3521476